Interlude
STUDY IDENTIFIER:
Interlude
CONDITION:
Moderate to Severe Mitral Regurgitation
CONTACT INFO:
Sara Olson, RN | sara.olson@allina.com | 612-863-7601
DESCRIPTION:
The purpose of this study is to assess the safety and performance of the Caisson Interventional Transcatheter MitralValve Replacement (TMVR) system for the treatment of severe symptomatic MitralValve Regurgitation (MR). This study will provide initial information on the safety and performance of this system.
CRITERIA LIST/ QUALIFICATIONS:
- Severe mitral regurgitation
- NYHA Class II, III or IVa or heart failure
- High risk for cardiovascular surgery
INVESTIGATORS:
Mario Goessl, MD
SPONSORS:
Caisson
STATUS:
Open/Enrolling